Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Resmed Inc shares valued at $27,436 were purchased by Rider Michael J on Oct 01 ’25. At $274.36 per share, Rider Michael J acquired 100 shares.
Also, Sandercock Brett purchased 3,000 shares, netting a total of over 823,080 in proceeds.
Before that, Farrell Michael J. had sold 8,009 shares from its account. In a trade valued at $2,227,590, the Chief Executive Officer traded Resmed Inc shares for $278.14 each. Upon closing the transaction, the insider’s holdings decreased to 8,009 shares, worth approximately $126.7 million.
As published in their initiating research note from Citigroup on September 18, 2025, Resmed Inc [RMD] has been a Buy and the price target has been revised to $330. Analysts at CLSA upgraded the stock from ‘”a Hold”‘ to ‘”an Outperform”‘ outlook in a report released in early September. As of July 15, 2025, RBC Capital Mkts has increased its “Sector perform” rating to a “an Outperform” for RMD. Earlier on March 19, 2025, Morgan Stanley initiated its rating. Their recommendation was “an Overweight” for RMD stock.
Analyzing RMD Stock Performance
On last trading session, Resmed Inc [NYSE: RMD] plunged -1.05% to $270.85. The stock’s lowest price that day was $267.64, but it reached a high of $276.005 in the same session. During the last five days, there has been a drop of approximately -1.22%. Over the course of the year, Resmed Inc shares have jumped approximately 13.33%. Shares of the company reached a 52-week high of $293.81 on 08/22/25 and a 52-week low of $199.92 on 04/07/25.
Support And Resistance Levels for Resmed Inc (RMD)
According to the 24-hour chart, there is a support level at 266.69, which, if violated, would cause prices to drop to 262.54. In the upper region, resistance lies at 275.95. The next price resistance is at 281.06. RSI (Relative Strength Index) is 45.52 on the 14-day chart, showing neutral technical sentiment.
Is Resmed Inc subject to short interest?
Stocks of Resmed Inc saw a sharp steep in short interest on 2025-09-15 dropping by -0.29 million shares to 8.65 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 8.94 million shares. A decline of -3.33% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 8.77 of the overall float, the days-to-cover ratio (short ratio) decline to 8.77.
Which companies own the most shares of Resmed Inc (RMD)?
In terms of Resmed Inc share price expectations, FactSet research, analysts set an average price target of 274 in the next 12 months, up nearly 0.1% from the previous closing price of $273.73. Analysts anticipate Resmed Inc stock to reach 286 by 2025, with the lowest price target being 265. In spite of this, 19 analysts ranked Resmed Inc stock as Buy at the end of 2025.
